J&J taps AlivaMab for multi-target antibody discovery effort

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 16, 2019 at 9:32 AM.

  1. #1 cafead, Sep 16, 2019 at 9:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,925
    Likes Received:
    3
    via Johnson & Johnson has tasked AlivaMab Discovery Services with finding antibody-drug candidates against multiple targets. The project is built on the AlivaMab Mouse platform that is already used by in-house R&D teams at large biopharma companies.

    article source
     
    Quote

Reply to Thread